One fix for four Indias
India's health-insurance debate argues about one number: how much cover to add. That is the wrong question. India does not run one health system that needs more of something. It runs four systems under one name, and each one breaks at a different point in the same six-step journey from staying well to follow-up. So a single national fix lands on the wrong break for three of the four. Except one. But one fix comes closer than any other, and it is the cheapest thing on the table: it needs no new pool, no new premium and no new scheme. I named these four Indias in Edition 54. This one is about what to do with them.
↑ smaller, better served · larger, thinner cover ↓
Self-pay and premium insurance. Access complete, coordination absent. Sets the prices and holds the data the other three tiers are measured against.
Employer cover, ESIC, CGHS. Best access, worst continuity. Money stops at the first visit and again after discharge; the record does not survive a job change.
The missing middle. Own pocket and borrowing, no pool at all. One admission is paid for with savings, a loan or a sold asset.
PM-JAY and state schemes. Free once admitted, paying at every step before it.
01 — The wrong axis
The debate measures the wrong thing
Every reform conversation runs along one line: more insurance, or less. But cover is not a single gap you can widen. NFHS-6 puts household health-cover at 60.2%, up from 41%, which sounds like steady progress until you see that the 60% is four different situations wearing one number. The affluent household with a policy that excludes outpatient care, the salaried worker whose cover vanishes at a job change, the shopkeeper with nothing, and the scheme-enrolled family that pays for everything short of admission, all get counted the same way. The number hides the problem instead of measuring it.
02 — Four different breaks
Same chain, four different places it snaps
Follow any household through six steps, staying well, first visit, tests, treatment, bill paid, follow-up, and watch three things try to flow alongside them: the patient, the money, and the medical record. Each tier breaks somewhere different. India A carries all the way to discharge, then the record stops and nobody owns the follow-up. India B1 has the best access but the money stops at the first visit, because outpatient care is excluded, and again after discharge. India B2 breaks almost everywhere, and the hospital bill itself gets paid out of savings, a loan or a sold asset. India C is free once admitted and paying at every step before it.
03 — Why one fix can't fit all
The favourite fixes each help one tier and miss three
This is why the popular fixes disappoint. Expand hospital insurance and you serve India C's admission and India A's surgery, while B1 and B2 keep paying cash for the outpatient care that never gets covered. Build tertiary hospitals and you help whoever can already reach them. Even the money that is spent lands in the wrong place: out-of-pocket is still 43.4% of all health spending, and for India C, non-medical costs like travel, lodging and food are 23.6% of what a covered hospital stay still costs the family. And the schemes themselves are a state lottery, household cover under PM-JAY-type schemes runs from 21% in Bihar to 90% in Chhattisgarh. "India is covered" is a sentence about Chhattisgarh.
04 — The one line that reaches all four
Every tier is exposed on medicines. Only medicines reach every tier.
Here is the exception. Medicines are 60.3% of all outpatient out-of-pocket spending, and that holds for the affluent household paying cash for a monthly refill and for the scheme-covered household whose health centre has run out. It does not depend on your income, your employer or your state. It is the one bill all four Indias pay directly.
And India already built the fix. Jan Aushadhi generic stores sell at 50 to 80% below branded equivalents and already sit in 776 of 784 districts. Yet they hold about 1% of a roughly ₹1.5 lakh crore medicine market. The shops are there. The prescriptions are not.
The fix in one line: put the molecule name on every prescription, on a digital rail, with the price difference shown at the point of writing. No new pool, no actuary, no premium. It needs less new money than anything else on the table, though it still needs stock on the shelf, pharmacists allowed to swap, and states willing to enforce it. Nothing else on this list reaches an affluent household and a scheme-covered one on the same day.
05 — So what
Stop widening one number. Fix the joins.
For policy: prescribe by molecule, by default
Mandate generic-name prescribing on the digital health rail (ABDM) and show the Jan Aushadhi price next to the branded one as the doctor writes it. Writing the molecule name only saves money if three things follow: the medicine is actually in stock, the pharmacist is allowed and paid to swap it, and the patient trusts the cheaper box. Fix those three and this costs less than any other reform on the table.
For insurers and financing: cover the chain, not the admission
In three of the four tiers the break is outpatient: the first visit, the test, the monthly refill, not the hospital stay. Products and schemes built around a ₹5 lakh admission miss where the money actually leaks. The opportunity is recurring outpatient cover priced to the tier.
For digital health: the rails already decide who wins
Generic substitution, a portable record that survives a job change, and a referral that pays the informal first provider are all rail problems, not hospital problems. Whoever gets the molecule, the record and the referral to travel is building the layer all four Indias share.
Find your own tier. Two companion tools go with this edition: a six-question check that tells you which of the four Indias you are actually in, and the full value chain tier by tier. Which India are you in? → · The value chain, tier by tier →
As Edition 54 put it, "pan-India" is usually a lie the average tells. India runs four health systems, and the standard reflex, add more insurance, aims at the one break three of them do not have. The single line that reaches all four is not a new scheme or a bigger pool. It is the molecule name on the prescription. India already built the shops. It forgot to write the scripts.